Alcon stock gains after Q2 2026 earnings beat and outlook raise
Published on 09/14/2026 at 14:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Alcon Inc. (ISIN CH0432492467) stock closed at USD 66.03 on the New York Stock Exchange on September 11, 2026, giving the Swiss eye-care group a market capitalization of around USD 32.08 billion and reflecting the impact of a recent earnings beat and outlook raise in Q2 2026.
Q2 2026 earnings beat supports Alcon stock
According to Pluang, Alcon reported earnings per share of USD 0.84 in Q2 2026, ahead of market expectations and providing a key catalyst for the recent performance of Alcon stock in September 2026.
The same overview notes that Alcon simultaneously raised its profit outlook for the 2026 financial year alongside the Q2 2026 results, signalling management confidence in the trajectory of earnings and reinforcing the fundamental case for investors tracking Alcon stock.Pluang
Revenue and margin context around the latest figures
For historical context, Pluang reports that revenue for fiscal year 2025 reached USD 10.40 billion, while net income stood at USD 980 million, implying a net margin of about 9.42 percent for that year.
The same source highlights that margin pressure seen in fiscal year 2025 has eased as Alcon moved through 2026, with the Q2 2026 earnings beat and raised 2026 profit outlook pointing to improving profitability compared with the 9.42 percent net margin recorded in fiscal year 2025.Pluang
Swiss listing shows intraday gains on September 14, 2026
On the home market in Switzerland, Alcon shares were among the positive performers in the SMI at midday on September 14, 2026, with the stock gaining 1.6 percent to 54.86 Swiss francs in SIX Swiss Exchange trading, according to finanzen.ch.
The same report indicates that Alcon shares on SIX Swiss Exchange reached a day high of 54.88 Swiss francs and opened the session at 54.46 Swiss francs on September 14, 2026, while the SMI index was quoted around 13,940 points, underscoring that Alcon stock participated in a broader positive market tone.finanzen.ch
Next earnings date provides a clear calendar marker
An analyst overview cited in recent commentary lists November 10, 2026 as the next scheduled earnings date for Alcon, giving investors a clear point at which the company is expected to update the market on its performance and progress against the raised 2026 profit outlook.Ad-hoc-news
Alcon stock price level and valuation snapshot
On its primary listing at the New York Stock Exchange, Alcon stock closed at USD 66.03 on September 11, 2026, marking a decline of 0.78 percent compared with the prior close and placing the shares below typical analyst consensus price targets referenced in recent overviews.Ad-hoc-news
The same data set values Alcon at around USD 32.08 billion as of September 11, 2026, providing a reference point for investors comparing the company with other global eye-care and medical technology groups in terms of market capitalization.Ad-hoc-news
Closing price and investor takeaway
Alcon stock therefore stands at USD 66.03 on the New York Stock Exchange as of September 11, 2026, in United States dollars, with investors closely watching whether the Q2 2026 earnings beat, raised 2026 profit outlook and upcoming earnings date on November 10, 2026 will translate into further gains from the current valuation level.
Alcon stock key data
- Company: Alcon Inc.
- ISIN: CH0432492467
- Ticker: ALC
- Trading venue: New York Stock Exchange
- Price (as of September 11, 2026): 66.03 USD
- Market capitalization: 32.08 billion USD (as of September 11, 2026)
- Sector / Industry: Health care / Medical technology
- Index membership: SMI
- Next earnings date: November 10, 2026
